Literature DB >> 12079729

Genome scan for susceptibility loci for schizophrenia and bipolar disorder.

Ursula Bailer1, Friedrich Leisch, Kurt Meszaros, Elisabeth Lenzinger, Ulrike Willinger, Rainer Strobl, Angela Heiden, Christian Gebhardt, Elisabeth Döge, Karoline Fuchs, Werner Sieghart, Siegfried Kasper, Kurt Hornik, Harald N Aschauer.   

Abstract

BACKGROUND: Despite the widely accepted view that schizophrenia and bipolar disorder represent independent illnesses and modes of inheritance, some data in the literature suggest that the diseases may share some genetic susceptibility. The objective of our analyses was to search for vulnerability loci for the two disorders.
METHODS: A genomewide map of 388 microsatellite DNA markers was genotyped in five schizophrenia and three bipolar disorder Austrian families. Linkage analyses was used to compute the usual parametric logarithm of the likelihood of linkage (LOD) scores and nonparametric linkage analysis (NPL scores Z(all)) was used to assess the pattern of allele sharing at each marker locus relative to the presence of the disease (GENEHUNTER). Affected status was defined as severe affective disorder or schizophrenia.
RESULTS: Across the genome, p values associated with NPL scores resulted in evidence (i.e., p <.0007) for linkage at marker D3S1265 on chromosome 3q (NPL score Z (all) = 3.74, p =.0003). Two other markers (on 3q and 6q) showed p values of <.01.
CONCLUSIONS: We detected a potential susceptibility locus for bipolar disorder and schizophrenia on chromosome 3q, which has not been reported previously. The possibility of a false positive result has to be taken into account. Our data suggest shared loci for schizophrenia and bipolar affective disorders and are consistent with the continuum model of psychosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079729     DOI: 10.1016/s0006-3223(02)01320-3

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  22 in total

1.  Intraesophageal manganese superoxide dismutase-plasmid liposomes ameliorates novel total-body and thoracic radiation sensitivity of NOS1-/- mice.

Authors:  Malolan S Rajagopalan; Brandon Stone; Jean-Claude Rwigema; Umar Salimi; Michael W Epperly; Julie Goff; Darcy Franicola; Tracy Dixon; Shaonan Cao; Xichen Zhang; Bettina M Buchholz; Anthony J Bauer; Serah Choi; Christopher Bakkenist; Hong Wang; Joel S Greenberger
Journal:  Radiat Res       Date:  2010-09       Impact factor: 2.841

2.  Genomewide scan for affective disorder susceptibility Loci in families of a northern Swedish isolated population.

Authors:  Tine Venken; Stephan Claes; Samuel Sluijs; Andrew D Paterson; Cornelia van Duijn; Rolf Adolfsson; Jurgen Del-Favero; Christine Van Broeckhoven
Journal:  Am J Hum Genet       Date:  2004-12-21       Impact factor: 11.025

3.  Genetic Association Analysis of NOS1 and Methamphetamine-Induced Psychosis Among Japanese.

Authors:  Takenori Okumura; Tomo Okochi; Taro Kishi; Masashi Ikeda; Tsuyoshi Kitajima; Yoko Kinoshita; Kunihiro Kawashima; Tomoko Tsunoka; Yasuhisa Fukuo; Toshiya Inada; Mitsuhiko Yamada; Naohisa Uchimura; Masaomi Iyo; Ichiro Sora; Norio Ozaki; Hiroshi Ujike; Nakao Iwata
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

4.  Nicotine intake and smoking topography in smokers with bipolar disorder.

Authors:  Jill M Williams; Kunal K Gandhi; Shou-En Lu; Marc L Steinberg; Neal L Benowitz
Journal:  Bipolar Disord       Date:  2012-09       Impact factor: 6.744

5.  Sensory gating and alpha-7 nicotinic receptor gene allelic variants in schizoaffective disorder, bipolar type.

Authors:  Laura F Martin; Sherry Leonard; Mei-Hua Hall; Jason R Tregellas; Robert Freedman; Ann Olincy
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-07-05       Impact factor: 3.568

6.  Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder.

Authors:  Colin A Hodgkinson; David Goldman; Judith Jaeger; Shalini Persaud; John M Kane; Robert H Lipsky; Anil K Malhotra
Journal:  Am J Hum Genet       Date:  2004-09-22       Impact factor: 11.025

7.  No association between polymorphisms of neuronal oxide synthase 1 gene (NOS1) and schizophrenia in a Japanese population.

Authors:  Takenori Okumura; Tomo Okochi; Taro Kishi; Masashi Ikeda; Tsuyoshi Kitajima; Yoshio Yamanouchi; Yoko Kinoshita; Kunihiro Kawashima; Tomoko Tsunoka; Hiroshi Ujike; Toshiya Inada; Norio Ozaki; Nakao Iwata
Journal:  Neuromolecular Med       Date:  2009-06-10       Impact factor: 3.843

8.  GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.

Authors:  Hui Tang; Na Shen; Huijuan Jin; Dan Liu; Xiaoping Miao; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2013-02-27       Impact factor: 5.590

9.  Association of common variants in the Joubert syndrome gene (AHI1) with autism.

Authors:  Ana I Alvarez Retuerto; Rita M Cantor; Joseph G Gleeson; Anna Ustaszewska; Wendy S Schackwitz; Len A Pennacchio; Daniel H Geschwind
Journal:  Hum Mol Genet       Date:  2008-09-09       Impact factor: 6.150

Review 10.  GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder.

Authors:  Michael K Rowe; Charlotte Wiest; De-Maw Chuang
Journal:  Neurosci Biobehav Rev       Date:  2007-03-15       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.